DOI: 10.3724/SP.J.1008.2015.01388

Academic Journal of Second Military Medical University (第二军医大学学报) 2015/36:12 PP.1388-1392

Effects of residual renal function on uremic toxicity level of patients undergoing high-flux dialysis


Key words:24 h-residual urine volume;maintenance hemodialysis;high flux hemodialysis;β2-microglobulin;parathyroid hormone

ReleaseDate:2016-05-27 09:20:04

[1] Yoshino M, Kuhlmann M K, Kotanko P, Greenwood R N, Pisoni R L, Port F K, et al.International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality[J]. J Am Soc Nephrol, 2006, 17:3510-3519.

[2] Ward R A. Do clinical outcomes in chronic hemodialysis depend on the choice of a dialyzer?[J].Semin Dial, 2011, 24:65-71.

[3] DiRaimondo C R, Pollak V E. Beta 2-microglobulin kinetics in maintenance hemodialysis: a comparison of conventional and high-flux dialyzers and the effects of dialyzer reuse[J]. Am J Kidney Dis, 1989, 13:390-395.

[4] Port F K, Wolfe R A, Hulbert-Shearon T E, Daugirdas J T, Agodoa L Y, Jones C, et al. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the usrds dialysis morbidity and mortality study[J].Am J Kidney Dis, 2001, 37:276-286.

[5] Chauveau P, Nguyen H, Combe C, Chêne G, Azar R, Cano N, et al. Dialyzer membrane permeability and survival in hemodialysis patients[J].Am J Kidney Dis, 2005, 45:565-571.

[6] Krane V, Krieter D H, Olschewski M, März W, Mann J F, Ritz E, et al. Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis[J]. Am J Kidney Dis, 2007, 49:267-275.

[7] Eknoyan G, Beck G J, Cheung A K, Daugirdas J T, Greene T, Kusek J W, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis[J].N Engl J Med, 2002, 347:2010-2019.

[8] Locatelli F, Martin-Malo A, Hannedouche T, Loureiro A, Papadimitriou M, Wizemann V, et al. Effect of membrane permeability on survival of hemodialysis patients[J]. J Am Soc Nephrol, 2009, 20:645-654.

[9] Cheung A K, Rocco M V, Yan G, Leypoldt J K, Levin N W, Greene T, et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study[J].J Am Soc Nephrol, 2006, 17:546-555.

[10] Shemin D, Bostom A G, Laliberty P, Dworkin L D. Residual renal function and mortality risk in hemodialysis patients[J].Am J Kidney Dis, 2001, 38:85-90.

[11] Vilar E, Wellsted D, Chandna S M, Greenwood R N, Farrington K. Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose[J].Nephrol Dial Transplant, 2009, 24:2502-2510.

[12] van der Wal W M, Noordzij M, Dekker F W, Boeschoten E W, Krediet R T, Korevaar J C, et al. Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structural model[J].Nephrol Dial Transplant, 2011, 26: 2978-2983.

[13] Eichner T, Radford S E. Understanding the complex mechanisms of β2-microglobulin amyloid assembly[J].FEBS J, 2011, 278: 3868-3883.

[14] Kim H W, Kim S H, Kim Y O, Jin D C, Song H C, Choi E J, et al. Comparison of the impact of high-flux dialysis on mortality in hemodialysis patients with and without residual renal function[J].PLoS One, 2014, 9:e97184.

[15] Tattersall J, Canaud B, Heimburger O, Pedrini L, Schneditz D, van Biesen W; European Renal Best Practice advisory Board. High-flux or low-flux dialysis: a position statement following publication of the Membrane Permeability Outcome study[J].Nephrol Dial Transplant, 2010, 25:1230-1232.

[16] Tsukamoto Y, Hanaoka M, Matsuo T, Saruta T, Nomura M, Takahashi Y. Effect of 22-oxacalcitriol on bone histology of hemodialyzed patients with severe secondary hyperparathyroidism[J]. Am J Kidney Dis, 2000, 35:458-464.

[17] Kudlac H, Fielding A M, Williams A J. Effect of hemodialysis membrane type on parathyroid hormone removal[J].Miner Electrolyte Metab, 1994, 20:245-249.

[18] Vanholder R C, Glorieux G L, De Smet R V. Back to the future: middle molecules, high flux membranes, and optimal dialysis[J]. Hemodial Int, 2003, 7:52-57.

[19] Silver J, Levi R. Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease[J]. Kidney Int, 2005, 67:S8-S12.

[20] Grant F D, Conlin P R, Brown E M. Rate and concentration dependence of parathyroid hormone dynamics during stepwise changes in serum ionized calcium in normal humans[J].J Clin Endocrinol Metab, 1990, 71:370-378.

[21] Lindsay R M, Spanner E. A hypothesis: the protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients[J].Am J Kidney Dis, 1989, 13:382-389.

[22] Marcus R G, Cohl E, Uribarri J. Middle molecule clearance does not influence protein intake in hemodialysis patients[J].Am J Kidney Dis, 1998, 31:491-494.

[23] Johansen K L, Mulligan K, Tai V, Schambelan M. Leptin, body composition, and indices of malnutrition in patients on dialysis[J]. J Am Soc Nephrol, 1998, 9:1080-1084.

[24] Bergstrom J. Mechanisms of uremic suppression of appetite[J].J Ren Nutr, 1999, 9:129-132.